Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
暂无分享,去创建一个
Jack Gauldie | Nik Hirani | S. Forbes | J. Gauldie | A. MacKinnon | T. Sethi | T. Delaine | Stuart J Forbes | Hakon Leffler | A. Simpson | Ulf J Nilsson | Sarah L Farnworth | N. Hirani | U. Nilsson | M. Gibbons | Sarah L. Farnworth | H. Leffler | A John Simpson | Tamara Delaine | Tariq Sethi | Alison C Mackinnon | Michael A Gibbons
[1] M. Selman,et al. Idiopathic pulmonary fibrosis: misunderstandings between epithelial cells and fibroblasts? , 2004, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[2] P. Sime,et al. TGF-β, Smad3 and the process of progressive fibrosis , 2007 .
[3] F. Graham,et al. Adenovirus‐Vector‐Mediated Cytokine Gene Transfer to Lung Tissue a , 1996, Annals of the New York Academy of Sciences.
[4] Rakesh K. Kumar. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder , 2002, Respiratory Research.
[5] B. Willis,et al. TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease , 2007 .
[6] J. Dennis,et al. Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis , 2004, Science.
[7] D. Warburton,et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[8] Bernhard Schmierer,et al. TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.
[9] K. Csaky,et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.
[10] T. Bringman,et al. Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. , 1990, Journal of neuroimmunology.
[11] A. Brody,et al. Isolation and primary culture of murine alveolar type II cells. , 1996, American journal of respiratory cell and molecular biology.
[12] G. Oster,et al. Incidence and prevalence of idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.
[13] C. Heldin,et al. Non-Smad TGF-beta signals. , 2005, Journal of cell science.
[14] M. Rekhter,et al. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. , 1994, The American journal of pathology.
[15] P. O'Byrne,et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[16] H. Chapman,et al. Integrin α3β1–dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts , 2009, The Journal of cell biology.
[17] M. Selman,et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? , 2000, American journal of physiology. Lung cellular and molecular physiology.
[18] B. Willis,et al. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[19] P. Wolters,et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. , 2008, The Journal of clinical investigation.
[20] G. Rosen,et al. SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of β-Catenin* , 2010, The Journal of Biological Chemistry.
[21] P. Sime,et al. TGF-beta, Smad3 and the process of progressive fibrosis. , 2007, Biochemical Society transactions.
[22] E. Hay,et al. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. , 2005, Cells, tissues, organs.
[23] R. Bucala,et al. Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.
[24] R. Strawderman,et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. , 2001, The American journal of medicine.
[25] J. Iredale,et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. , 2008, The American journal of pathology.
[26] Jack Gauldie,et al. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. , 2005, Journal of immunology.
[27] K. Moon,et al. Activation of the TGF- β/Smad signaling pathway in focal segmental glomerulosclerosis , 2003 .
[28] C. Heldin,et al. Non-Smad TGF-β signals , 2005, Journal of Cell Science.
[29] S. Forbes,et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. , 2011, American journal of respiratory and critical care medicine.
[30] P. Sime,et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. , 2002, American journal of respiratory cell and molecular biology.
[31] H. Tagami,et al. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. , 1997, Journal of cutaneous pathology.
[32] Samy Lamouille,et al. TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.
[33] A. Pardo,et al. Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.
[34] G. Servillo,et al. Galectin‐1 exerts immunomodulatory and protective effects on concanavalin a–induced hepatitis in mice , 2000, Hepatology.
[35] T. Sjöblom,et al. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. , 2008, Oncogene.
[36] M. Selman,et al. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.
[37] Jack Gauldie,et al. TGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis1 , 2005, The Journal of Immunology.
[38] T. Farncombe,et al. Journal of Translational Medicine Comparison between Conventional and "clinical" Assessment of Experimental Lung Fibrosis , 2008 .
[39] H. Tagami,et al. Inverse correlation between CD34 expression and proline‐4‐hydroxyase immunoreactivity on spindle cells noted in hypertrophic scars and keloids , 1997 .
[40] T. Bringman,et al. Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis , 1990, Journal of Neuroimmunology.
[41] A. Nicholson,et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. , 2005, The American journal of pathology.
[42] E. Hay,et al. Transforming Growth Factor-β Signaling during Epithelial-Mesenchymal Transformation: Implications for Embryogenesis and Tumor Metastasis , 2005, Cells Tissues Organs.
[43] M. Selman,et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. , 2008, The international journal of biochemistry & cell biology.
[44] P. Minoo,et al. Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis. , 2011, The Journal of clinical investigation.
[45] H. Friess,et al. Galectin-1 and Galectin-3 in Chronic Pancreatitis , 2000, Laboratory Investigation.
[46] D. Postma,et al. House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. , 2010, American journal of respiratory cell and molecular biology.
[47] C. McCulloch,et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. , 2004, The American journal of pathology.
[48] D. Warburton,et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? , 2008, The international journal of biochemistry & cell biology.
[49] D. Sheppard,et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix , 2006, Proceedings of the National Academy of Sciences.
[50] G. Raghu. Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches , 2006, European Respiratory Journal.
[51] K. Nitta,et al. Suppression of renal fibrosis by galectin-1 in high glucose-treated renal epithelial cells. , 2010, Experimental cell research.
[52] J. Iredale,et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[53] R. Mason,et al. TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) , 2005, Respiratory research.
[54] S. Kimmel,et al. Effect of treatment guidelines on the initial management of idiopathic pulmonary fibrosis. , 2010, British journal of clinical pharmacology.
[55] G. Laurent,et al. Pulmonary fibrosis: searching for model answers. , 2005, American journal of respiratory cell and molecular biology.
[56] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[57] S. Kimmel,et al. Factors associated with the use of corticosteroids in the initial management of idiopathic pulmonary fibrosis , 2010, Pharmacoepidemiology and drug safety.
[58] E. Hay,et al. Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. , 2006, Molecular biology of the cell.
[59] M. Burdick,et al. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. , 2007, Biochemical and biophysical research communications.
[60] J. Wrana,et al. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. , 2003, Nature cell biology.
[61] W. Fung-Leung,et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. , 2000, The American journal of pathology.
[62] C. McCulloch,et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. , 2004, The American journal of pathology.
[63] G. Rabinovich,et al. Galectin-1 suppresses experimental colitis in mice. , 2003, Gastroenterology.